What is a lethal dose of Klonopin

Potential for dependence on pregabalin

1 Pfizer Europe MA EEIG: Information for professionals "Lyrica® hard capsules". Status: May 2019.

2 Bonnet U, Scherbaum N: On the addiction potential of gabapentinoids. Fortschr Neurol Psychiatr 2018; 86: 82-105.

3 Schwabe U: anti-epileptic drugs. In: Schwabe U, Paffrath D, Ludwig W-D, Klauber J (eds.). Drug Ordinance Report 2019. Berlin, Heidelberg: Springer-Verlag, 2019; 497-511.

4 Bonnet U, Scherbaum N: How addictive are gabapentin and pregabalin? A systematic review. Eur Neuropsychopharmacol 2017; 27: 1185-1215.

5 FDA: FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR): https://www.fda.gov/media/133681/download (last access : January 8, 2020). FDA Drug Safety Communications; London, December 19, 2019.

6 Evoy KE, Morrison MD, Saklad SR: Abuse and Misuse of Pregabalin and Gabapentin. Drugs 2017; 77: 403-426.

7 Knecht B, Lohmüller J, Telschow C: Supplementary statistical overview. In: Schwabe U, Paffrath D, Ludwig W-D, Klauber J (eds.). Drug Ordinance Report 2019. Berlin, Heidelberg: Springer-Verlag, 2019; 1037-1102.

8 Viniol A, Ploner T, Hickstein L et al .: Prescribing practice of pregabalin / gabapentin in pain therapy: an evaluation of German claim data. BMJ Open 2019; 9: e021535.

9 Guglielmo R, Martinotti G, Clerici M, Janiri L: Pregabalin for alcohol dependence: a critical review of the literature. Adv Ther 2012; 29: 947-957.

10 Mason BJ, Crean R, Goodell V et al .: A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults. Neuropsychopharmacology 2012; 37: 1689-1698.

11 Drug Commission of the German Medical Association: "From the ADR database": Potential for dependence on pregabalin (Lyrica®). Dtsch Arztebl 2011; 108: A 183.

12 Gahr M, Freudenmann RW, Kolle MA, Schonfeldt-Lecuona C: From benzodiazepine to pregabalin dependence: Different agents, similar problems. Indian J Psychiatry 2015; 57: 111-112.

13 Grosshans M, Mutschler J, Hermann D et al .: Pregabalin abuse, dependence, and withdrawal: a case report. On J Psychiatry 2010; 167: 869.

14 Kulaksizoglu B, Kara H, Bodur B, Kuloglu M: Intravenous buprenorphine / naloxone and concomitant oral pregabalin misuse: a case report. Neuropsychiatr Dis Treat 2018; 14: 3033-3035.

15 Driot D, Chicoulaa B, Jouanjus E et al .: Pregabalin use disorder and secondary nicotine dependence in a woman with no substance abuse history. Therapy 2016; 71: 575-578.

16 Halaby A, Kassm SA, Naja WJ: Pregabalin dependence: a case report. Curr Drug Saf 2015; 10: 184-186.

17 Al-Husseini A, Wazaify M, Van Hout MC: Pregabalin Misuse and Abuse in Jordan: a Qualitative Study of User Experiences. Int J Ment Health Addict 2018; 16: 642-654.

18 Schifano F, D'Offizi S, Piccione M et al .: Is there a recreational misuse potential for pregabalin? Analysis of anecdotal online reports in comparison with related gabapentin and clonazepam data. Psychother Psychosom 2011; 80: 118-122.

19 Lyndon A, Audrey S, Wells C et al .: Risk to heroin users of polydrug use of pregabalin or gabapentin. Addiction 2017; 112: 1580-1589.

20 Snellgrove BJ, Steinert T, Jaeger S: Pregabalin Use Among Users of Illicit Drugs: A Cross-Sectional Survey in Southern Germany. CNS Drugs 2017; 31: 891-898.

21 Chiappini S, Schifano F: A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency's 'Suspected Adverse Drug Reactions' Database. CNS Drugs 2016; 30: 647-654.